Xarelto Lawsuit Update: Case Numbers Rising in Philadelphia Mass Tort Group

November 13, 2015 – – BloodThinnerHelp.com reports today on the development of the Philadelphia mass tort group that was created for the ongoing Xarelto litigation. The Philadelphia mass tort group was created after a motion was made to consolidate the growing number of cases filed against the manufacturers of Xarelto in the area. There are currently 478 cases filed in the mass tort group. The number of cases filed has consistently been on the rise and is expected to continue to grow as time moves on.

The litigation is still in the pretrial and discovery stages and trials are not expected to start for quite some time. The mass tort group is consolidated in the Philadelphia court of Common Pleas’s Complex Litigation Center. For more detailed information on the litigation process, visit this page.

Allegations Made Against Xarelto Manufacturers:

The lawsuits in the Philadelphia mass tort group are able to be consolidate because they all make similar allegations against the same defendants, in this case the defendants are the manufacturers of Xarelto, Bayer AG and Janssen Pharmaceuticals. The lawsuits filed all generally allege that Xarelto causes uncontrollable internal bleeding that can lead to serious injury and even death in patients, that the manufacturers of Xarelto failed to adequately warn patients and doctors about real dangers of the drug and provide them with information on how to stabilize patients experiencing an adverse reaction, and that the manufacturers of Xarelto were negligent in releasing the drug onto the market without a corresponding antidote. For a full list of the cases filed, click here.

Lawsuits Allege Lack of Antidote is Negligent:

These lawsuits allege that Xarelto is significantly more dangerous than other blood thinners on the market because Xarelto does not have a corresponding antidote available. This means that if a patient taking Xarelto suffers from an internal bleeding injury, that internal bleed can become uncontrollable because there is no way to stop the bleeding. This is what has led to the injury of many of the plaintiffs in the mass tort group and it is a very different situation than patients who are taking other blood thinners, such as Warfarin, are in. If a patient taking Warfarin experiences an internal bleed, a doctor will be able to simply administer vitamin K to the patient and their blood will clot again.

Lawsuits Filed Seeking Internal Bleeding and Wrongful Death Damages:

Many of the lawsuits filed in the mass tort group are internal bleeding and wrongful death lawsuits. These lawsuits are seeking compensation for damages such as the costs of medical treatment, hospital bills, loss of wages, loss of future earnings, loss of companionship, and in the case of wrongful death, funeral and burial expenses.

For any questions regarding this press release or the pending Xarelto litigation, please contact Marc Goldich at (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Marc Goldich
866-425-8902
1500 Walnut Street, 4th Floor, Philadelphia, PA 19102.

ReleaseID: 60005417